Bristol Myers rises after boosting FY revenue view, topping Q3 results
** Shares of Bristol-Myers Squibb BMY.N rise 2.2% to $61.94 premarket
** Pharma giant raises annual revenue forecast to a range of $49.75 billion to $50.25 billion from a previous view of $49.0 billion to $50.0 billion
** Co reports Q3 adj. EPS of $1.35, topping analysts' average estimate of $1.14, according to LSEG-compiled data
** BMY posts Q3 revenue of $13.1 billion, vs estimates of $12.75 billion
** Co now expects 2026 adjusted earnings of $6.35 to $6.55 per share versus a previous projection of $6.75 to $7.00 apiece
** As of last close, BMY stock was up 12.3% YTD